Convalescent plasma is one of several emerging therapies. However, there is no robust evidence to support it for routine therapy
from Current Affairs https://ift.tt/3ccHoa0
from Current Affairs https://ift.tt/3ccHoa0
Clinical trial begins to assess plasma efficacy to limit Covid-19: ICMR
![Clinical trial begins to assess plasma efficacy to limit Covid-19: ICMR]()
Reviewed by শ্রী শ্রী সত্যনারায়ণ নমঃ
on
May 07, 2020
Rating:
No comments: